Frequency of memory cytotoxic T lymphocytes to equine infectious anemia virus proteins in blood from carrier horses

Virology

Volumn 238, Issue 1, 1997, Pages 85-93

  McGuire, Travis C ^a   Zhang, Wei ^a   Hines, Melissa T ^a   Henney, Pamela J ^b   Byrne, Katherine M ^a  

^a WASHINGTON STATE UNIVERSITY   (United States)

^b UNIVERSITY OF KENTUCKY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DIFFERENTIATION ANTIGEN; EPITOPE; VIRUS ENVELOPE PROTEIN; VIRUS PROTEIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELLULAR IMMUNITY; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; EQUINE INFECTIOUS ANEMIA VIRUS; HORSE; NONHUMAN; PRIORITY JOURNAL;

ANIMALIA; EQUIDAE; EQUINE INFECTIOUS ANEMIA VIRUS; EQUUS CABALLUS; LENTIVIRUS; VACCINIA; VACCINIA VIRUS;

EID: 0031564060     PISSN: 00426822     EISSN: None     Source Type: Journal    
DOI: 10.1006/viro.1997.8795     Document Type: Article

References (41)

1. Allen, G., Yeargan, M., Costa, L., and Cross, R. (1995). Major histocompatibility complex class I-restricted cytotoxic T-lymphocyte responses in horses infected with herpesvirus I. J. Virol. 69, 606-612.
2. Bailey, E. (1980). Identification and genetics of horse lymphocyte alloantigens. Immunogenetics 11, 499-506.
3. Bailey, E. (1983). Population studies on the ELA system in American standardbred and thoroughbred mares. Anim. Blood Groups Biochem. Genet. 14, 201-211.
4. Carmichael, A., Jn, X., Sissons, P., and Borysiewicz, L. (1993). Quantitative analysis of the human immunodeficiency virus type 1 (HIV-1)-specific cytotoxic T lymphocyte (CTL) response at different stages of HIV-1 infection: Differential CTL responses to HIV-1 and Epstein-Barr virus in late disease. J. Exp. Med. 177, 249-256.
5. Carpenter, S., Evans, L., Sevoian, M., and Chesebro, B. (1987). Role of host immune response in selection of equine infectious anemia virus variants. J. Virol. 61, 3783-3789.
6. Coggins, L. (1984). Carriers of equine infectious anemia virus. J. Am. Vet. Med. Assoc. 184, 279-281.
7. Coggins, L., Norcross, N. L., and Nusbaum, S. R. (1972). Diagnosis of equine infectious anemia by immunodiffusion test. Am. J. Vet. Res. 33, 11-18.
8. Davis, W., Marusic, S., Lewin, H., Splitter, G., Perryman, L., McGuire, T., and Gorham, J. (1987). The development and analysis of species specific and cross reactive monoclonal antibodies to leukocyte differentiation antigens and antigens of the major histocompatibility complex for use in the study of the immune system in cattle and other species. Vet. Immunol. Immunopathol. 15, 337-376.
9. Fazekas De St. Groth, S. (1982). The evaluation of limiting dilution assays. J. Immunol. Methods 49, R11-R23.
10. Freundlich, B., and Avdalovic, N. (1983). Use of gelatin/plasma coated flasks for isolating human peripheral blood monocytes. J. Immunol. Methods 62, 31-37.
11. Fujimiya, Y., Perryman, L., and Crawford, T. (1979). Leukocyte cytotoxicity in a persistent virus infection: Presence of direct cytotoxicity but absence of antibody-dependent cellular cytotoxicity in horses infected with equine infectious anemia virus. Infect. Immun. 24, 628-636.
12. Hammond, S., Cook, S., Lichtenstein, D., Issel, C., and Montelaro, R. (1997). Maturation of the cellular and humoral immune responses to persistent infection in horses by equine infectious anemia virus is a complex and lengthy process. J. Virol. 71, 3840-3852.
13. Harrer, T., Harrer, E., Kalams, S., Barbosa, P., Trocha, A., Johnson, R., Elbeik, T., Feinberg, M., Buchbinder, S., and Walker, B. (1996). Cytotoxic T lymphocytes in asymptomatic long-term nonprogressing infection. Breath and specificity of the response and relation to in vivo viral quasispecies in a person with prolonged infection and low viral load. J. Immunol. 156, 2616-2623.
14. Hoffenbach, A., Langlade-Demoyen, P., Dadaglio, G., Vilmer, E., Michel, F., Mayaud, C., Autran, B., and Plata, F. (1989). Unusually high frequencies of HIV-specific cytotoxic T lymphocytes in humans. J. Immunol. 142, 452-462.
15. Issel, C., Adams, W., Meek, L., and Ochoa, R. (1982). Transmission of equine infectious anemia virus from horses without clinical signs of disease. J. Med. Virol. 27, 293-298.
16. Issel, C., Horohov, D., Lea, D., Adams, W., Hagius, S., McManus, J., Allison, A., and Montelaro, R. (1992). Efficacy of inactivated whole-virus and subunit vaccine in preventing infection and disease caused by equine infectious anemia virus. J. Virol. 66, 3398-3408.
17. Kono, Y. (1969). Viremia and immunological responses in horses infected with equine infectious anemia virus. Natl. Inst. Anim. Health Quart. 9, 1-9.
18. Kono, Y., Fukunaga, Y., and Kobayashi, K. (1973a). Resistance of horses infected chronically with equine infectious anemia virus against reinfection. Natl. Inst. Anim. Health Quart. 13, 173-181.
19. Kono, Y., Hirasawa, K., Fukunaga, Y., and Taniguchi, T. (1976). Recrudescence of equine infectious anemia by treatment with immunosuppressive drugs. Natl. Inst. Anim. Health Quart. 16, 8-15.
20. Kono, Y., Kobayashi, K., and Fukunaga, Y. (1973b). Antigenic drift of equine infectious anemia virus in chronically infected horses. Arch. Gesamte Virusforsch. 41, 1-10.
21. Kydd, J., Antczak, D., Allen, W., Barbis, D., Butcher, G., Davis, W., Duffus, W., Edington, N., Grunig, G., Holmes, M., Lunn, D., McCulloch, J., O'Brien, A., Perryman, L., Tavenor, A., Williamson, S., and Zhang, C. (1994). Report of the first international workshop on equine leucocyte antigens, Cambridge, UK, July 1991. Vet. Immunol. Immunopathol. 42, 3-60.
22. Langemeier, J., Cook, S., Cook, R., Rushlow, K., Montelaro, R., and Issel, C. (1996). Detection of equine infectious anemia viral RNA in plasma samples from recently infected and long-term inapparent carrier animals by PCR. J. Clin. Microbiol. 34, 1481-1487.
23. Lazary, S., Antczak, D., Bailey, E., Bell, T., Bernoco, D., Byrns, G., and McClure, J. (1988). Joint report of the fifth international workshop on lymphocyte alloantigens of the horse, Baton Rouge, Louisiana, 31 October-1 November 1987. Anim. Genet. 19, 447-456.
24. Magnuson, N., Perryman, L, Wyatt, C., Mason, P., and Talmadge, J. (1987). Large granular lymphocytes from SCID horses develop potent cytotoxic activity after treatment with human recombinant IL-2. J. Immunol. 139, 61-67.
25. Malmquist, W., Barnett, D., and Becvar, C. (1973). Production of equine infectious anemia antigen in a persistently infected cell line. Arch. Gesamte Virusforsch. 42, 361-370.
26. Maury, W. (1994). Monocyte maturation controls expression of equine infectious anemia virus. J. Virol. 68, 6270-6279.
27. McGuire, T., Banks, K., and Poppie, M. (1975). Combined immunodeficiency in horses: Characterization of the lymphocyte defect. Clin. Immuno. Immunopathol. 3, 555-566.
28. McGuire, T., O'Rourke, K., Baszier, T., Leib, S., Brassfield, A., and Davis, W. (1994a). Expression of functional protease and subviral particles by vaccinia virus containing equine infectious anemia virus gag and 5′ pol genes. J. Gen. Virol. 75, 895-900.
29. + cytotoxic T lymphocytes from horses with equine infectious anemia virus recognize env and gag/PR proteins. J. Virol. 68, 1459-1467.
30. Montelaro, R., Parekh, B., Orrego, A., and Issel, C. (1984). Antigenic variation during persistent infection by equine infectious anemia virus, a retrovirus. J. Biol. Chem. 259, 10539-10544.
31. Orrego, A., Issel, C., Montelaro, R., and Adams, W. (1982). Virulence and in vitro growth of a cell-adapted strain of equine infectious anemia virus after serial passage in ponies. Am. J. Vet. Res. 43, 1556-1560.
32. O'Rourke, K., Perryman, L., and McGuire, T. (1988). Antiviral, anti-glycoprotein and neutralizing antibodies in foals with equine infectious anaemia virus. J. Gen. Virol. 69, 667-674.
33. O'Rourke, K., Perryman, L., and McGuire, T. (1989). Cross-neutralizing and subclass characteristics of antibody from horses with equine infectious anemia virus. Vet. Immunol. Immunopathol. 23, 41-49.
34. Perryman, L., O'Rourke, K., and McGuire, T. (1988). Immune responses are required to terminate viremia in equine infectious anemia lentivirus infection. J. Virol. 62, 3073-3076.
35. Rinaldo, C., Huang, X., Fan, Z., Ding, M., Beltz, L., Logar, A., Panicali, D., Mazzara, G., Liebmann, J., Cottrill, M., and Gupta, P. (1995). High levels of anti-human immunodeficiency virus type 1 (HIV-1) memory cytotoxic T-lymphocyte activity and low viral load are associated with lack of disease in HIV-1-infected long-term nonprogressors. J. Virol. 69, 5838-5842.
36. Rushlow, K., Chong, Y., Ball, J., Issel, C., and Montelaro, R. (1990). Evaluation of protective host immune responses during persistent infection with EIAV. In "Proceedings 5th Colloque des Cent Garde. Retroviruses of Human AIDS and Related Animal Diseases" (M. Girard and L. Valette, Eds.), pp. 133-138. Foundation Merieux, Lyon, France.
37. Rwambo, P., Issel, C., Adams, W., Hussain, K., Miller, M., and Montelaro, R. (1990). Equine infectious anemia virus: Humoral responses of recipient ponies and antigenic variation during persistent infection. Arch. Virol. 111, 199-212.
38. Siliciano, R., Keegan, A., Dintzis, R., Dintzis, H., and Shin, S. (1985). The interaction of nominal antigen with T cell antigen receptors. I. Specific binding of multivalent nominal antigen to cytolytic T cell clones. J. Immunol. 135, 906-914.
39. Tschetter, J., Byrne, K., Perryman, L., and McGuire, T. (1997). Control of equine infectious anemia virus is not dependent on ADCC mediating antibodies. Virology 230, 275-280.
40. + T lymphocyte depletion in normal and equine infectious anaemia virus-carrier horses. J. Gen. Virol. 75, 959-968.
41. Wyatt, C., Davis, W., McGuire, T., and Perryman, L. (1988). T lymphocyte development in horses. I. Characterization of monoclonal antibodies identifying three stages of T lymphocyte differentiation. Vet. Immunol. Immunopathol. 18, 3-18.